Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

The U.S. scientific community is slowly chipping away at the lack of diversity seen in medical research, but it still has a long way to go, experts tell Axios.

Why it matters: "We are not a nation of white men," LA BioMed's David Meyer says. Because race and ethnicity sometimes play a role in how people develop diseases or react to medications, it's important in this age of "personalized medicine" to expand research to include people of color, the elderly, poorer communities, and those in the LGBTQ community.

Driving the news: The National Institutes of Health earlier this week discussed progress made in the first year of its All of Us program, which aims to enroll at least 1 million people from all types of U.S. communities over a 5-year period.

  • The program was created because "we're making a lot of scientific conclusions based on a small slice of the population," Stephanie Devaney, deputy director of All of Us, tells Axios.
  • "We're excited" that roughly 80% of program participants self-identify as being in at least 1 of the 9 categories of underrepresented populations, Devaney says.
  • "We want to study the human lifespan," Devaney says. "What are the elements of a person's life we can capture or understand why some remain healthy and others don't?"
  • "I'm most excited that we're getting ready to roll out the genomics program," Devaney says. "I'm [also] personally excited about the possibilities of learning more on social determinants of health that will go beyond our biology."

But there's much progress still to be made, experts say.

  • One example is apparent in the announcement earlier this week by the Centers for Disease Control and Prevention that maternity mortality rates remain high, with American Indian/Alaska Native and black women 3 times more likely to die than white women, particularly in the year after giving birth.
  • While growing research shows the serious problem of bias in health care professionals and lack of health care access for underrepresented groups, this doesn't always explain the whole problem, notes Jane Delgado, president and CEO
    of the National Alliance for Hispanic Health.
  • For instance, Delgado tells Axios that the Hispanic community also faces problems from bias, but that their maternity mortality rate is actually lower than white women (11.4 deaths per 100,000 live births compared with 13 deaths of white mothers.)

What they're saying: Experts urge increased focus on bolstering research to develop precision medicine.

"Diversity in medical research is becoming increasingly important as the population becomes increasingly diverse. Consequently, investment in precision medicine is only as good as the genetic knowledge bank we are able to accumulate. By conducting clinical trials and research that reflect the citizens they aim to help, the industry is better able to accurately identify specific disease markers and new rare diseases that are unique to various races and ethnicities."
— David Meyer
"Changes in the way we approach science is a major step and that's where All of Us comes in. ... Science, community, and culture together — that's where the rubber meets the road."
— Jane Delgado

The bottom line: As the U.S. population continues to change, medical research needs to actively seek participants from all communities to understand the role that genetics, socioeconomic and lifestyle factors play in a person developing disease or chronic conditions.

Go deeper:

Go deeper

Ina Fried, author of Login
4 mins ago - Technology

Google's parent shuts down effort to deliver internet via balloons

Image: Loon

Alphabet is shutting down Loon, one of its "moonshots," which aimed to deliver internet service via high-altitude balloons.

Why it matters: The effort was one of several approaches designed to get high-speed connectivity to some of the world's most remote spots and proved useful in the aftermath of disasters that shut down traditional infrastructure.

Dave Lawler, author of World
20 mins ago - World

What has and hasn't changed as Biden takes over U.S. foreign policy

Photo Illustration: Brendan Lynch/Axios. Photo: Chip Somodevilla/Getty Images

President Biden swiftly recommitted the U.S. to the Paris climate pact and the World Health Organization, but America's broader foreign policy is in a state of flux between the Trump and Biden eras.

Driving the news: One of the most striking moves from the Biden administration thus far was a show of continuity — concurring with the Trump administration's last-minute determination that China had committed "genocide" against Uyghur Muslims.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: New coronavirus cases down, but more bad news ahead — Fighting COVID-19's effects on gender equality.
  2. Politics: Biden unveils "wartime" COVID strategyBiden's COVID-19 bubble.
  3. Vaccine: NYC postpones vaccine appointments following shipment delays — Private companies step in to fill vaccine logistics vacuum.
  4. World: Biden will order U.S. to rejoin World Health OrganizationBiden to bring U.S. into global COVAX initiative for equitable vaccine access.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!